Roche and CombiMatrix look to microarrays:
This article was originally published in Clinica
Executive Summary
Roche Diagnostics is to partner with CombiMatrix, a wholly owned subsidiary of Acacia Research of Pasadena, California, to develop microarray semiconductors to eventually perform genetically based diagnostics. Roche will begin selling the devices next year to research laboratories and will pay a royalty and product payments for the next three years.